Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working
Photo: NYT PoliticsResearchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib
Originally published by NYT Politics. Summary and curation by DutyStation News.